New Delhi, Nov 12 (PTI) Drug firm Glenmark Pharmaceuticals on Friday reported a 17.44 per cent jump in its consolidated net profit to Rs 274.80 crore for the quarter ended September 30, 2021.

The company had posted a net profit of Rs 233.99 crore for the corresponding period of the previous fiscal, Glenmark Pharmaceuticals said in a regulatory filing.

Also Read | .

Its consolidated revenue from operations during July-September 2021 stood at Rs 3,147.44 crore. It was Rs 2,952.47 crore for the same period a year ago, it added.

Glenmark Pharmaceuticals Chairman and MD Glenn Saldanha said, "We delivered yet another quarter of consistent performance, both in revenue growth and profitability. We have continued to perform well in our core therapy areas and launched differentiated products."

Also Read | Vivo Y15s With Android 11 Go Edition Launched; Prices, Features & Specifications.

Shares of Glenmark Pharmaceuticals on Friday closed at Rs 523.65 per scrip on the BSE, up 1.68 per cent from its previous close. HRS hrs

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)